ArticleBMC medicine2026
Impact of atrial fibrillation on clinical outcomes in 28,492 patients following open-heart cardiac valve surgery: A statewide population-linkage study.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAtrial fibrillation (AF) is common after cardiac surgery. Few studies compared clinical outcomes associated with AF between patients undergoing aortic valve surgery (AVSx) versus mitral valve surgery (MVSx).
methodsPatients who had open-heart cardiac valve surgery (1- July-2003 to 31-March-2021) identified from the Admitted-Patient-Data-Collection database in Australia were stratified by AF status (No-AF vs. New-AF vs. Prior-AF during index valve surgery) and followed up to 31-March-2022. Multivariable Cox regression and Fine-Gray competing risk analyses were performed to assess the association of AF status on all-cause mortality and non-fatal outcomes respectively.
resultsThe cohort comprised 28,492 patients (whole cohort median age 71.6yrs [interquartile range 62.7-78.3yrs]; 65.6% males): AVSx, n = 18,949, median age 73.3 [IR 65.4-79.4yrs], 67.8% males; MVSx, n = 9543, MVSx: median age 67.6 [IR 58.2-75.5yrs], 61.2% males. During a median 6.58yrs (3.4-10.5yrs) follow-up, Prior-AF and New-AF patients had significantly higher all-cause mortality (AVSx-Prior-AF: 57.9% vs. AVSx-New-AF: 41.5% vs. AVSx-No-AF: 32.8%; MVSx-Prior-AF: 41.0% vs. MVSx-New-AF: 29.8% vs. MVSx-No-AF: 22.4%) (both logrank P < 0.001). In the AVSx subgroup, both New-AF and Prior-AF were independently associated with all-cause mortality (aHR = 1.16, 95%CI = 1.10-1.22; aHR = 1.69, 95%CI = 1.59-1.79 respectively) compared to No-AF patients. In the MVSx subgroup, only Prior-AF was associated with increased all-cause mortality (aHR = 1.47, 95% CI = 1.33-1.61), all P < 0.001. Ischaemic stroke was significantly higher in the AVSx New-AF and AVSx-Prior-AF subgroups.
conclusionsPatients undergoing valve surgery have different risks of adverse clinical outcomes, with target valve and baseline AF status being associated with these outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.